DMAC
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- DiaMedica dosed the first patients in a Phase 2 trial of DM199 for fetal growth restrictionJun 23, 2026
- DiaMedica received FDA feedback on the nonclinical development program for DM199 in preeclampsiaJun 16, 2026
- DiaMedica Therapeutics reaches 75% enrollment milestone in the ReMEDy2 Phase 2/3 acute ischemic stroke trialMay 20, 2026
- DiaMedica Therapeutics reports positive interim Phase 2 results for preeclampsia: significant blood pressure reductions and no placental transferJul 17, 2025